Europe Genomics Market Size, Share & Industry Trends Analysis Report By Product & Service, By Application, By End User, By Technology, By Country, Historical Data and Growth Forecast, 2021 - 2027

The Europe Genomics Market would witness market growth of 17.0% CAGR during the forecast period (2021-2027).

Clinicians of all specialties can use genomic technologies to diagnose patients with high-risk genetic flaws that cause disease. Genomic technologies are rapidly being employed to better understand the role of rare and common genetic variables in the development of common diseases like hypertension, diabetes, and cancer.

Prenatal genetic screening systems are expected to increase rapidly in the near future. This is due to the fact that these programs assist pregnant moms in detecting genetic abnormalities in their children. Moreover, it is anticipated that in the next 10 years, every newborn’s genome would be sequenced and stored in the electronic medical record. Emerging companies like Counsyl and Natera have released several genetic tests to get a competitive advantage in the industry, gauging the future market potential of genomics in newborn screening programs.

The UK government announced the 100,000 Genomes Project in 2012 with the goal of sequencing 100,000 human genomes, establishing a genomic medicine service for the NHS, enabling new scientific discoveries. It has received over £200 million in funding and would initially focus on rare diseases and cancer. Hence, these factors are estimated to open new growth avenues for the regional Genomics Market during the forecasting period.

The Germany market dominated the Europe Genomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $4,750.1 million by 2027. The UK market would showcase a CAGR of 16.1% during (2021 - 2027). Additionally, The France market is experiencing a CAGR of 17.9% during (2021 - 2027).

Based on Product & Service, the market is segmented into Consumables, Systems & Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on Technology, the market is segmented into Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Genomics Market Size will Hit $68.9 Billion by 2027, at a CAGR of 17.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product & Service

• Consumables
• Systems & Software and
• Services

By Application

• Drug Discovery & Development
• Diagnostics
• Agriculture & Animal Research and
• Others

By End User

• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Pharmaceutical & Biotechnology Companies and
• Others

By Technology

• Sequencing
• PCR
• Nucleic Acid Extraction & Purification
• Microarray, and
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Creative Biogene
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Agilent Technologies, Inc.
• Hoffmann-La Roche Ltd.
• Eurofins Scientific Group
• Qiagen N.V.
• New England BioLabs, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genomics Market, by Product & Service
1.4.2 Europe Genomics Market, by Application
1.4.3 Europe Genomics Market, by End User
1.4.4 Europe Genomics Market, by Technology
1.4.5 Europe Genomics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players

Chapter 4. Europe Genomics Market by Product & Service
4.1 Europe Consumables Market by Country
4.2 Europe Systems & Software Market by Country
4.3 Europe Services Market by Country

Chapter 5. Europe Genomics Market by Application
5.1 Europe Drug Discovery & Development Market by Country
5.2 Europe Diagnostics Market by Country
5.3 Europe Agriculture & Animal Research Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Genomics Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Research Centers and Academic & Government Institutes Market by Country
6.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Genomics Market by Technology
7.1 Europe Sequencing Market by Country
7.2 Europe PCR Market by Country
7.3 Europe Nucleic Acid Extraction & Purification Market by Country
7.4 Europe Microarray Market by Country
7.5 Europe Others Market by Country

Chapter 8. Europe Genomics Market by Country
8.1 Germany Genomics Market
8.1.1 Germany Genomics Market by Product & Service
8.1.2 Germany Genomics Market by Application
8.1.3 Germany Genomics Market by End User
8.1.4 Germany Genomics Market by Technology
8.2 UK Genomics Market
8.2.1 UK Genomics Market by Product & Service
8.2.2 UK Genomics Market by Application
8.2.3 UK Genomics Market by End User
8.2.4 UK Genomics Market by Technology
8.3 France Genomics Market
8.3.1 France Genomics Market by Product & Service
8.3.2 France Genomics Market by Application
8.3.3 France Genomics Market by End User
8.3.4 France Genomics Market by Technology
8.4 Russia Genomics Market
8.4.1 Russia Genomics Market by Product & Service
8.4.2 Russia Genomics Market by Application
8.4.3 Russia Genomics Market by End User
8.4.4 Russia Genomics Market by Technology
8.5 Spain Genomics Market
8.5.1 Spain Genomics Market by Product & Service
8.5.2 Spain Genomics Market by Application
8.5.3 Spain Genomics Market by End User
8.5.4 Spain Genomics Market by Technology
8.6 Italy Genomics Market
8.6.1 Italy Genomics Market by Product & Service
8.6.2 Italy Genomics Market by Application
8.6.3 Italy Genomics Market by End User
8.6.4 Italy Genomics Market by Technology
8.7 Rest of Europe Genomics Market
8.7.1 Rest of Europe Genomics Market by Product & Service
8.7.2 Rest of Europe Genomics Market by Application
8.7.3 Rest of Europe Genomics Market by End User
8.7.4 Rest of Europe Genomics Market by Technology

Chapter 9. Company Profiles
9.1 Creative Biogene
9.1.1 Company Overview
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.10. New England BioLabs, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:

TABLE 1 Europe Genomics Market, 2017 - 2020, USD Million
TABLE 2 Europe Genomics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Genomics Market
TABLE 4 Product Launches And Product Expansions– Genomics Market
TABLE 5 Acquisition and Mergers– Genomics Market
TABLE 6 Europe Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 7 Europe Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 8 Europe Consumables Market by Country, 2017 - 2020, USD Million
TABLE 9 Europe Consumables Market by Country, 2021 - 2027, USD Million
TABLE 10 Europe Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 11 Europe Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 12 Europe Services Market by Country, 2017 - 2020, USD Million
TABLE 13 Europe Services Market by Country, 2021 - 2027, USD Million
TABLE 14 Europe Genomics Market by Application , 2017 - 2020, USD Million
TABLE 15 Europe Genomics Market by Application , 2021 - 2027, USD Million
TABLE 16 Europe Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 17 Europe Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 18 Europe Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 19 Europe Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 20 Europe Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 21 Europe Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 22 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 23 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 24 Europe Genomics Market by End User, 2017 - 2020, USD Million
TABLE 25 Europe Genomics Market by End User, 2021 - 2027, USD Million
TABLE 26 Europe Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 27 Europe Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 28 Europe Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 29 Europe Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 30 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 31 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 32 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 33 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 34 Europe Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 35 Europe Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 36 Europe Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 37 Europe Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 38 Europe PCR Market by Country, 2017 - 2020, USD Million
TABLE 39 Europe PCR Market by Country, 2021 - 2027, USD Million
TABLE 40 Europe Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 41 Europe Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 42 Europe Microarray Market by Country, 2017 - 2020, USD Million
TABLE 43 Europe Microarray Market by Country, 2021 - 2027, USD Million
TABLE 44 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 45 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 46 Europe Genomics Market by Country, 2017 - 2020, USD Million
TABLE 47 Europe Genomics Market by Country, 2021 - 2027, USD Million
TABLE 48 Germany Genomics Market, 2017 - 2020, USD Million
TABLE 49 Germany Genomics Market, 2021 - 2027, USD Million
TABLE 50 Germany Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 51 Germany Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 52 Germany Genomics Market by Application , 2017 - 2020, USD Million
TABLE 53 Germany Genomics Market by Application , 2021 - 2027, USD Million
TABLE 54 Germany Genomics Market by End User, 2017 - 2020, USD Million
TABLE 55 Germany Genomics Market by End User, 2021 - 2027, USD Million
TABLE 56 Germany Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 57 Germany Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 58 UK Genomics Market, 2017 - 2020, USD Million
TABLE 59 UK Genomics Market, 2021 - 2027, USD Million
TABLE 60 UK Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 61 UK Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 62 UK Genomics Market by Application , 2017 - 2020, USD Million
TABLE 63 UK Genomics Market by Application , 2021 - 2027, USD Million
TABLE 64 UK Genomics Market by End User, 2017 - 2020, USD Million
TABLE 65 UK Genomics Market by End User, 2021 - 2027, USD Million
TABLE 66 UK Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 67 UK Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 68 France Genomics Market, 2017 - 2020, USD Million
TABLE 69 France Genomics Market, 2021 - 2027, USD Million
TABLE 70 France Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 71 France Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 72 France Genomics Market by Application , 2017 - 2020, USD Million
TABLE 73 France Genomics Market by Application , 2021 - 2027, USD Million
TABLE 74 France Genomics Market by End User, 2017 - 2020, USD Million
TABLE 75 France Genomics Market by End User, 2021 - 2027, USD Million
TABLE 76 France Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 77 France Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 78 Russia Genomics Market, 2017 - 2020, USD Million
TABLE 79 Russia Genomics Market, 2021 - 2027, USD Million
TABLE 80 Russia Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 81 Russia Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 82 Russia Genomics Market by Application , 2017 - 2020, USD Million
TABLE 83 Russia Genomics Market by Application , 2021 - 2027, USD Million
TABLE 84 Russia Genomics Market by End User, 2017 - 2020, USD Million
TABLE 85 Russia Genomics Market by End User, 2021 - 2027, USD Million
TABLE 86 Russia Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 87 Russia Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 88 Spain Genomics Market, 2017 - 2020, USD Million
TABLE 89 Spain Genomics Market, 2021 - 2027, USD Million
TABLE 90 Spain Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 91 Spain Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 92 Spain Genomics Market by Application , 2017 - 2020, USD Million
TABLE 93 Spain Genomics Market by Application , 2021 - 2027, USD Million
TABLE 94 Spain Genomics Market by End User, 2017 - 2020, USD Million
TABLE 95 Spain Genomics Market by End User, 2021 - 2027, USD Million
TABLE 96 Spain Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 97 Spain Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 98 Italy Genomics Market, 2017 - 2020, USD Million
TABLE 99 Italy Genomics Market, 2021 - 2027, USD Million
TABLE 100 Italy Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 101 Italy Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 102 Italy Genomics Market by Application , 2017 - 2020, USD Million
TABLE 103 Italy Genomics Market by Application , 2021 - 2027, USD Million
TABLE 104 Italy Genomics Market by End User, 2017 - 2020, USD Million
TABLE 105 Italy Genomics Market by End User, 2021 - 2027, USD Million
TABLE 106 Italy Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 107 Italy Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 108 Rest of Europe Genomics Market, 2017 - 2020, USD Million
TABLE 109 Rest of Europe Genomics Market, 2021 - 2027, USD Million
TABLE 110 Rest of Europe Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 111 Rest of Europe Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 112 Rest of Europe Genomics Market by Application , 2017 - 2020, USD Million
TABLE 113 Rest of Europe Genomics Market by Application , 2021 - 2027, USD Million
TABLE 114 Rest of Europe Genomics Market by End User, 2017 - 2020, USD Million
TABLE 115 Rest of Europe Genomics Market by End User, 2021 - 2027, USD Million
TABLE 116 Rest of Europe Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 117 Rest of Europe Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 118 Key Information – Creative Biogene
TABLE 119 Key Information – Thermo Fisher Scientific, Inc.
TABLE 120 key information – Illumina, Inc.
TABLE 121 Key Information – Bio-Rad Laboratories, Inc.
TABLE 122 Key Information – Danaher Corporation
TABLE 123 key Information – Agilent Technologies, Inc.
TABLE 124 key information – F. Hoffmann-La Roche Ltd.
TABLE 125 Key Information – Eurofins Scientific Group
TABLE 126 Key Information –Qiagen N.V.
TABLE 127 Key Information – New England BioLabs, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, dec) Leading Players
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: Illumina, Inc.
FIG 7 Recent strategies and developments: Bio-Rad laboratories, Inc.
FIG 8 Recent strategies and developments: Agilent Technologies, Inc.
FIG 9 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 10 Recent strategies and developments: Qiagen N.V.